{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:26:11Z","timestamp":1792524371003,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1136\/ard.2010.140822","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T07:29:53Z","timestamp":1299050993000},"page":"823-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register"],"prefix":"10.1016","volume":"70","author":[{"given":"Suzanne M M","family":"Verstappen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath D","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P M","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.140822_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncprheum0426","article-title":"Drug insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.","volume":"3","author":"Skomsvoll","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1136\/ard.2010.140822_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.140822_bib3","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/art.22028","article-title":"Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register.","volume":"54","author":"Hyrich","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140822_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.315.7099.32","article-title":"Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice.","volume":"315","author":"Everett","year":"1997","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.140822_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1471-0528.2007.01426.x","article-title":"A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population.","volume":"115","author":"Blohm","year":"2008","journal-title":"BJOG"},{"key":"10.1136\/ard.2010.140822_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy.","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.140822_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbspin.2008.04.016","article-title":"Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature.","volume":"76","author":"Berthelot","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1136\/ard.2010.140822_bib8","first-page":"241","article-title":"The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.","volume":"30","author":"Chakravarty","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.140822_bib9","doi-asserted-by":"crossref","first-page":"iv18","DOI":"10.1136\/ard.2005.042549","article-title":"Biological drug use: US perspectives on indications and monitoring.","volume":"64","author":"Cush","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.140822_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2036.2005.02405.x","article-title":"Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.","volume":"21","author":"Mahadevan","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1136\/ard.2010.140822_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MCG.0b013e31817f9367","article-title":"Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.","volume":"43","author":"Kane","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1136\/ard.2010.140822_bib12","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/rheumatology\/ken168","article-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.","volume":"47","author":"Ostensen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.140822_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/rheumatology\/kem068","article-title":"Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.","volume":"46","author":"Rosner","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.140822_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/kel400","article-title":"Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.","volume":"46","author":"Roux","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.140822_bib15","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","article-title":"Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.","volume":"99","author":"Katz","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1136\/ard.2010.140822_bib16","first-page":"S682","article-title":"Pregnancy outcomes in women exposed to Adalimumab: OTIS autoimmune diseases in pregnancy project.","volume":"58","author":"Johnson","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.140822_bib17","first-page":"678","article-title":"Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).","volume":"27","author":"Mart\u00ednez Lopez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2010.140822_bib18","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study.","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.140822_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1034\/j.1600-0412.2000.079006490.x","article-title":"Pregnancy complications and delivery practice in women with connective tissue disease and inflammatory rheumatic disease in Norway.","volume":"79","author":"Skomsvoll","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ard.2010.140822_bib20","unstructured":"National Office for Statistics. Conceptions. 2010: http:\/\/www.statistics.gov.uk. (Data obtained 2009)."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724145839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.140822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:04:21Z","timestamp":1737349461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724145839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0003496724145839"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.140822","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.140822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}